×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Contexte :

 

Après plusieurs décennies sans avancées majeures, de nouvelles molécules viennent redéfinir la prise en charge des cancers de l’endomètre.

 

Deux experts vous partagent leur analyse des données actuelles et des dernières recommandations à travers des cas cliniques.

 

Experts :

 

Pr Jean-Sébastien Frenel - Oncologue médical, Institut de Cancérologie de l’Ouest, Saint-Herblain

Pr Isabelle Ray-Coquard - Oncologue médical, Centre Léon Bérard, Lyon

 

Programme :

 

- Présentation des recommandations de Saint Paul de Vence 2025 dans les cancers de l’endomètre avancé ou en rechute

Pr Jean Sébastien Frenel

 

- Cas clinique 1 : Prise en charge des tumeurs dMMR

Pr Isabelle Ray-Coquard

 

- Cas clinique 2 : Prise en charge des tumeurs pMMR

Pr Jean Sébastien Frenel

 

- Débat/Discussion & Réponses aux questions

 

Shooting date : 2025-06-11
Last update : 2025-06-12
Pr Jean-Sébastien Frenel
Saint-Herblain, France
Oncology

Suggestions

Wednesday, May 21st 2025 from 06pm to 07pm (GMT+2)
Honolulu : Wednesday, May 21st 2025 from 06am to 07am (GMT+2)
San Francisco : Wednesday, May 21st 2025 from 09am to 10am (GMT+2)
New York : Wednesday, May 21st 2025 from 12pm to 01pm (GMT+2)
Buenos Aires : Wednesday, May 21st 2025 from 01pm to 02pm (GMT+2)
Reykjavik : Wednesday, May 21st 2025 from 04pm to 05pm (GMT+2)
London / Dublin : Wednesday, May 21st 2025 from 05pm to 06pm (GMT+2)
Paris / Berlin : Wednesday, May 21st 2025 from 06pm to 07pm (GMT+2)
Istanbul : Wednesday, May 21st 2025 from 07pm to 08pm (GMT+2)
Moscou / Dubaï : Wednesday, May 21st 2025 from 08pm to 09pm (GMT+2)
Bangkok : Wednesday, May 21st 2025 from 11pm to 12am (GMT+2)
Shanghai : Thursday, May 22nd 2025 from 12am to 01am (GMT+2)
Tokyo : Thursday, May 22nd 2025 from 01am to 02am (GMT+2)
Sydney : Thursday, May 22nd 2025 from 03am to 04am (GMT+2)
Wellington : Thursday, May 22nd 2025 from 05am to 06am (GMT+2)

16e congrès de la SFCO

Carcinose

Share
Thursday, May 22nd 2025 from 09am to 06:30pm (GMT+2)
Honolulu : Wednesday, May 21st 2025 from 09pm to 06:30am (GMT+2)
San Francisco : Thursday, May 22nd 2025 from 12am to 09:30am (GMT+2)
New York : Thursday, May 22nd 2025 from 03am to 12:30pm (GMT+2)
Buenos Aires : Thursday, May 22nd 2025 from 04am to 01:30pm (GMT+2)
Reykjavik : Thursday, May 22nd 2025 from 07am to 04:30pm (GMT+2)
London / Dublin : Thursday, May 22nd 2025 from 08am to 05:30pm (GMT+2)
Paris / Berlin : Thursday, May 22nd 2025 from 09am to 06:30pm (GMT+2)
Istanbul : Thursday, May 22nd 2025 from 10am to 07:30pm (GMT+2)
Moscou / Dubaï : Thursday, May 22nd 2025 from 11am to 08:30pm (GMT+2)
Bangkok : Thursday, May 22nd 2025 from 02pm to 11:30pm (GMT+2)
Shanghai : Thursday, May 22nd 2025 from 03pm to 12:30am (GMT+2)
Tokyo : Thursday, May 22nd 2025 from 04pm to 01:30am (GMT+2)
Sydney : Thursday, May 22nd 2025 from 06pm to 03:30am (GMT+2)
Wellington : Thursday, May 22nd 2025 from 08pm to 05:30am (GMT+2)

16e congrès de la SFCO

Rediffusion en direct

Share
Monday, November 28th 2022 from 06pm to 07:30pm (GMT+1)
Honolulu : Monday, November 28th 2022 from 06am to 07:30am (GMT+1)
San Francisco : Monday, November 28th 2022 from 08am to 09:30am (GMT+1)
New York : Monday, November 28th 2022 from 11am to 12:30pm (GMT+1)
Buenos Aires : Monday, November 28th 2022 from 01pm to 02:30pm (GMT+1)
London / Dublin : Monday, November 28th 2022 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Monday, November 28th 2022 from 05pm to 06:30pm (GMT+1)
Istanbul : Monday, November 28th 2022 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Monday, November 28th 2022 from 08pm to 09:30pm (GMT+1)
Bangkok : Monday, November 28th 2022 from 11pm to 12:30am (GMT+1)
Shanghai : Tuesday, November 29th 2022 from 12am to 01:30am (GMT+1)
Tokyo : Tuesday, November 29th 2022 from 01am to 02:30am (GMT+1)
Sydney : Tuesday, November 29th 2022 from 02am to 03:30am (GMT+1)
Wellington : Tuesday, November 29th 2022 from 04am to 05:30am (GMT+1)

Prise en charge du cancer de l’ovaire avancé à l’ère de la médecine de précision en 2022

Share
Tuesday, January 31st 2023 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, January 31st 2023 from 06am to 07:30am (GMT+1)
San Francisco : Tuesday, January 31st 2023 from 08am to 09:30am (GMT+1)
New York : Tuesday, January 31st 2023 from 11am to 12:30pm (GMT+1)
Buenos Aires : Tuesday, January 31st 2023 from 01pm to 02:30pm (GMT+1)
London / Dublin : Tuesday, January 31st 2023 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Tuesday, January 31st 2023 from 05pm to 06:30pm (GMT+1)
Istanbul : Tuesday, January 31st 2023 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Tuesday, January 31st 2023 from 08pm to 09:30pm (GMT+1)
Bangkok : Tuesday, January 31st 2023 from 11pm to 12:30am (GMT+1)
Shanghai : Wednesday, February 1st 2023 from 12am to 01:30am (GMT+1)
Tokyo : Wednesday, February 1st 2023 from 01am to 02:30am (GMT+1)
Sydney : Wednesday, February 1st 2023 from 02am to 03:30am (GMT+1)
Wellington : Wednesday, February 1st 2023 from 04am to 05:30am (GMT+1)

Cancer de l'ovaire en 1L :

Actualités et options thérapeutiques disponibles en 2023

Share
Scroll Up